A review of 15 years of ovarian tissue bank activities
- 829 Downloads
To review 15 years of activities in ovarian tissue cryobanking from medical database files, including patient indications, histological evaluation and clinical characteristics.
Retrospective longitudinal analysis of data from an ovarian tissue bank in an academic hospital. Five hundred and eighty-two patients had their ovarian tissue cryobanked between April 1997 and January 2012. Analysis of cryobanking database: precryopreservation patient characteristics, indications and safety issues, laboratory files and postcryopreservation clinical data.
Of the 582 patients who had their ovarian tissue cryopreserved, 106 patients donated for research purposes and 476 patients for fertility preservation and long-term cryopreservation. Clinical data analysis of the 476 patients revealed a mean age at the time of cryopreservation of 23 ± 8.5 years (range: 9 months – 39 years), with 96.2 % of subjects aged ≤35 years (n = 458). Among 391 cases of malignant disease, hematological malignancies (39.9 %, n = 156) and breast cancer (21.7 %, n = 85) were the two main indications. At histology, malignant cells were found in ovarian tissue from leukemia patients (n = 3) and non-Hodgkin’s lymphoma patients (n = 2). Eleven patients underwent autotransplantation, resulting in 5 live births and 1 ongoing pregnancy.
This is the largest and most comprehensive study to describe and analyze indications and clinical patient characteristics before and after ovarian tissue cryopreservation. The procedure is safe, easy and promising. The database concept is a useful tool in patient selection for autotransplantation.
KeywordsChemotherapy Cancer Premature ovarian failure Ovarian tissue cryopreservation Database Malignant cells Cryobank
The present study was supported by grants from the Fonds National de la Recherche Scientifique de Belgique (grant Télévie N0 7.4507.10, grant 3.4.590.08 awarded to Marie-Madeleine Dolmans), the Fonds Spéciaux de Recherche, the Fondation Saint-Luc, the Foundation Against Cancer, and donations from Mr Pietro Ferrero, Baron Frère and Viscount Philippe de Spoelberch. We thank Mélanie Gorez and Cristina Marinescu for their help with data completion of the database.
- 16.Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, et al. Restoration of ovarian function after orthotopic (intraovarian and periovarian) transplantation of cryopreserved ovarian tissue in a woman treated by bone marrrow transplantation for sickle cell anaemia: case report. Hum Reprod. 2006;21:183–8.PubMedCrossRefGoogle Scholar
- 18.Donnez J, Jadoul P, Donnez O, Squifflet J, Gilliaux S, Dolmans M-M. How to preserve fertility before chemotherapy. BJMO. 2009;3:7–15.Google Scholar
- 41.Piver P, Amiot C, Agnani G, Pech J, Rohrlich PS, Vidal E, Aubard Y, Roux C (2009) Two pregnancies obtained after a new technique of autotransplantation of cryopreserved ovarian tissue. In: 25th Annual Meeting of ESHRE, 28 June–1 July, 2009. Amsterdam, the Netherlands: Oxford University Press, Hum Reprod i15.Google Scholar
- 45.Revelli A, Marchino G, Dolfin E, Molinari E, Delle Piane L, Salvagno F, et al. Live birth after orthotopic grafting of autologous cryopreserved ovarian tissue and spontaneous conception in Italy. Fertil Steril. 2012;S0015–0282(12):02248.Google Scholar
- 47.Rosendahl M, Timmermans Wielenga V, Nedergaard L, Kristensen SG, Ernst E, Rasmussen PE, et al. Cryopreservation of ovarian tissue for fertility preservation: no evidence of malignant cell contamination in ovarian tissue from patients with breast cancer. Fertil Steril. 2011;95:2158–61.PubMedCrossRefGoogle Scholar